PEG & ADCs
- ADC Drugs with New Targets Clinical Pipeline Review
- 11 FDA Approved Antibody-Drug Conjugates: An Overview
- Antibody Drug Conjugates (ADCs): Novel Linker Design
- History and Development of Antibody Drug Conjugates (ADCs)
- The History Of ADC Drugs Development
- FDA Approval of ZYNLONTA™ (loncastuximab tesirine-lpyl) - First CD19-targeted ADC
- Cleavable vs. Non-Cleavable Linkers in Antibody-Drug Conjugates
- A Novel Antibody Drug Conjugate Against Pancreatic Cancer
- ADCs, A Highly Targeted Drug Therapy For Cancer
- Progresses Of ADC Technology For Cancer Therapy